iHuman (NYSE:IH - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.07 earnings per share for the quarter, Zacks reports. iHuman had a net margin of 11.44% and a return on equity of 11.01%. The business had revenue of $29.00 million for the quarter.
iHuman Stock Up 5.7%
iHuman stock traded up $0.13 during midday trading on Friday, hitting $2.43. 39,100 shares of the stock were exchanged, compared to its average volume of 39,624. The company has a fifty day simple moving average of $2.28 and a two-hundred day simple moving average of $2.06. iHuman has a 52 week low of $1.47 and a 52 week high of $3.18. The stock has a market capitalization of $126.41 million, a PE ratio of 9.00 and a beta of 0.36.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in iHuman stock. Acadian Asset Management LLC acquired a new stake in iHuman Inc. Sponsored ADR (NYSE:IH - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 15,067 shares of the company's stock, valued at approximately $32,000. 4.92% of the stock is owned by institutional investors.
About iHuman
(
Get Free Report)
iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.
Featured Articles

Before you consider iHuman, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.
While iHuman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.